Discover 867 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
El Paso offers a variety of clinical research opportunities focused on conditions such as asthma, diabetes, arthritis, and Parkinson’s disease. The city’s growing healthcare sector is actively recruiting participants, providing access to cutting-edge treatments for both healthy volunteers seeking paid research studies and individuals looking for trials targeting specific health conditions.
Filter
2
Filter results
Results: 867
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
for
Generalized Myasthenia Gravis
Location: Fort Collins CO, Colorado Springs CO, Scottsdale AZ,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT04202341
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Fort Collins CO, Scottsdale AZ, Las Vegas NV, Tucson AZ,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT05006716
Phase1, Phase2, Recruiting
Dose-escalation Study of Oral CX-4945
for
Advanced Solid Tumors, Breast Cancer,
Location: Fort Collins CO, Loveland CO, Scottsdale AZ, Houston TX
Sponsor: Cylene Pharmaceuticals
Sex: All
Age: 18+
Code: NCT00891280
Phase1, Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
for
Nausea, Vomiting,
Location: Fort Collins CO, Ogden UT, Fort Worth TX, Irvine CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07169851
Phase2, Recruiting
Brain Injury Education and Outpatient Navigation-1stBIEN
for
Brain Injuries, Traumatic, Rehabilitation
Location: Colorado Springs CO, Dallas TX, Seattle WA
Sponsor: Seattle Children's Hospital
Sex: All
Age: 3+
Code: NCT05261477
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
for
Narcolepsy Type 1
Location: Colorado Springs CO, San Antonio TX, Santa Ana CA,
Sponsor: Takeda
Sex: All
Age: 16 - 70
Code: NCT05816382
Phase2, Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
for
Alzheimer's Disease
Location: Colorado Springs CO, Round Rock TX, Springfield IL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 60 - 70+
Code: NCT06976203
Phase3, Recruiting
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
for
Narcolepsy Type 2
Location: Colorado Springs CO, El Paso TX, Austin TX, St Louis MO,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06952699
Phase2, Recruiting
Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE
for
Hereditary Angioedema (HAE)
Location: Colorado Springs CO, Scottsdale AZ, Las Vegas NV,
Sponsor: Pharvaris Netherlands B.V.
Sex: All
Age: 12+
Code: NCT06679881
Phase3, Recruiting
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
for
Rheumatoid Arthritis
Location: Fort Collins CO, Albuquerque NM, Peoria AZ,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06972446
Phase2, Recruiting
Featured
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
for
Multiple Myeloma
Location: Denver CO, Scottsdale AZ, Minneapolis MN, Rochester MN,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07095452
Phase2, Phase3, Recruiting
Featured
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
for
Multiple Myeloma
Location: Denver CO, Salt Lake City UT, Dallas TX, Duarte CA,